Show simple item record

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

dc.contributor.authorFawsitt, CGen_US
dc.contributor.authorVickerman, Pen_US
dc.contributor.authorCooke, GSen_US
dc.contributor.authorWelton, NJen_US
dc.contributor.authorBarnes, Een_US
dc.contributor.authorBall, Jen_US
dc.contributor.authorBrainard, Den_US
dc.contributor.authorBurgess, Gen_US
dc.contributor.authorDillon, Jen_US
dc.contributor.authorFoster, Gen_US
dc.contributor.authorGore, Cen_US
dc.contributor.authorGuha, Nen_US
dc.contributor.authorHalford, Ren_US
dc.contributor.authorWhitby, Ken_US
dc.contributor.authorHolmes, Cen_US
dc.contributor.authorHowe, Aen_US
dc.contributor.authorHudson, Een_US
dc.contributor.authorHutchinson, Sen_US
dc.contributor.authorIrving, Wen_US
dc.contributor.authorKhakoo, Sen_US
dc.contributor.authorKlenerman, Pen_US
dc.contributor.authorMartin, Nen_US
dc.contributor.authorMassetto, Ben_US
dc.contributor.authorMbisa, Ten_US
dc.contributor.authorMcHutchison, Jen_US
dc.contributor.authorMcKeating, Jen_US
dc.contributor.authorMcLauchlan, Jen_US
dc.contributor.authorMiners, Aen_US
dc.contributor.authorMurray, Aen_US
dc.contributor.authorShaw, Pen_US
dc.contributor.authorSimmonds, Pen_US
dc.contributor.authorSpencer, Cen_US
dc.contributor.authorThomson, Een_US
dc.contributor.authorZitzmann, Nen_US
dc.contributor.authorConsortium, STOPHCVen_US
dc.date.accessioned2020-05-29T17:19:24Z
dc.date.available2019-08-26en_US
dc.date.issued2020-02en_US
dc.identifier.issn1098-3015en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/64480
dc.format.extent180 - 190en_US
dc.language.isoenen_US
dc.relation.ispartofVALUE IN HEALTHen_US
dc.rightsCreative Commons Attribution 4.0 International (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectbaseline testingen_US
dc.subjectcost-effectivenessen_US
dc.subjecthepatitis C virusen_US
dc.subjectresistance-associated polymorphismsen_US
dc.titleCost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virusen_US
dc.typeArticle
dc.rights.holder© 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research.
dc.identifier.doi10.1016/j.jval.2019.08.012en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000517813500007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume23en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International (CC BY 4.0)
Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International (CC BY 4.0)